UM researches awarded $1M to further research brain injury drug treatment

“This would be the first human clinical trial that’s been funded through UM.”

An accidental discovery by a University of Montana researcher may soon lead to the clinical testing of a new drug that limits the impacts of traumatic brain injury and reduces post-traumatic epilepsy in rats.

Research professor Dave Poulsen and members of his team in the Department of Biomedical and Pharmaceutical Sciences found that low doses of methamphetamine reduced brain damage in rats after a traumatic brain injury or stroke.

By Martin Kidston

Full Story: http://missoulian.com/news/local/um-researches-awarded-m-to-further-research-brain-injury-drug/article_4a61c020-1e7f-11e3-9641-0019bb2963f4.html